• to lessen the risk of severe cardiovascular (heart and blood vessel) difficulties in Grownups with type 2 diabetes and cardiovascular disease Novo Nordisk A/S is often a Danish multinational pharmaceutical company headquartered in Bagsværd,[3] with output facilities in nine natio